Purchase Order W81K0021P0085
- Not listed
- This is a $712,573.88 firm fixed price purchase order awarded by the Department of the Army Medical Command to Abbott Laboratories Inc. for the provision of clinical chemistry and immunoassay assays. The contract has no set-aside designation. Abbott Laboratories, through its Abbott Diagnostics Division, has provided a wide variety of laboratory equipment, reagents, and testing services to federal agencies including the Department of Veterans Affairs, Defense Health Agency, and Department of...
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded a Firm Fixed Price Delivery Order to Abbott Laboratories Inc., through its Abbott Diagnostics Division, for $252,345.56 in chemistry and immunoassay testing services. This award was not set aside and has a completion date of May 31, 2020. Abbott Laboratories is a large pharmaceutical and medical device manufacturer that has provided a wide variety of goods and services, including clinical laboratory equipment,...
- The Department of the Army Medical Command awarded a firm fixed price purchase order contract to Abbott Laboratories Inc. to provide an architect analyzer for chemistry and immunoassay testing. The contract period of performance is from October 1, 2022 to September 30, 2023 and the potential value is $178,501.00. The contract is not set aside for any specific business type. As a major medical device and pharmaceutical manufacturer, Abbott Laboratories provides a wide range of healthcare products...
- This is a federal contract award to Abbott Laboratories Inc. by the Department of the Army Medical Command for the provision of clinical chemistry and immunoassay supplies. The contract is a Delivery Order issued under Abbott's existing General Services Administration (GSA) Federal Supply Schedule contract for Critical Analyzers, Laboratory. The contract has a potential value of $2,511,922.58 and a completion date of October 31, 2021. No set-aside designation is specified. As a major...
- This federal contract award is for CHEMISTRY TESTING services provided by Abbott Laboratories Inc., a large pharmaceutical and medical device manufacturer, to the Department of the Army Medical Command. The $345,447.24 Firm Fixed Price contract was awarded on October 1, 2020 with a completion date of September 30, 2021. It was not set aside for any specific business type. Through its Abbott Diagnostics Division, Abbott has extensive experience providing a variety of clinical laboratory...
- The Department of the Army Medical Command awarded a firm fixed price purchase order contract to Abbott Laboratories Inc. for automated chemistry and immunoassay testing services. The $1,912,860.98 contract has a performance period through October 31, 2024 and was awarded on October 1, 2019. The services will be provided at Abbott's North Chicago, Illinois facility. This award is not associated with a set-aside program. Abbott Laboratories is a large pharmaceutical and medical device...
- This is a $345,447.24 firm fixed price delivery order contract awarded by the Department of the Army Medical Command to Abbott Laboratories Inc., a for-profit manufacturer, for chemistry testing services. The award is not associated with any set-aside designation. Abbott Laboratories Inc., through its Abbott Diagnostics Division, has an existing General Services Administration Federal Supply Schedule contract and has provided a variety of clinical laboratory goods and services to federal...
- This is a delivery order issued under the General Services Administration (GSA) Federal Supply Schedule for Critical Analyzers, Laboratory (FSS-66-III). The U.S. Department of Defense (DOD) Medical Command (MEDCOM) awarded a $535,432.75 firm-fixed-price contract to Abbott Laboratories Inc., through its Abbott Diagnostics Division, for in vitro reagents for pathology testing equipment. The award has no set-aside designation. Abbott Laboratories is a global healthcare company that provides a...
- This federal contract award is for the delivery of REAGENTS from Abbott Laboratories Inc. to the U.S. Department of the Army Medical Command (MEDCOM). The $156,353.35 firm fixed-price delivery order is issued under the Critical Analyzers, Laboratory Federal Supply Schedule (FSS-66-III) contract, a General Services Administration (GSA) indefinite delivery vehicle. No set-aside designation was used. Abbott Laboratories Inc., a global healthcare company, is the prime contractor. The award...
- This federal contract award to Abbott Laboratories Inc. is for the provision of CLINICAL CHEMISTRY/IMMUNOASSAY REAGENTS, awarded by the U.S. Army Medical Command (MEDCOM) under the General Services Administration (GSA) Federal Supply Schedule for Critical Analyzers, Laboratory (FSS-66-III). The contract has a ceiling value of $5,595,127.58 and is a Firm Fixed Price Delivery Order with a period of performance through March 31, 2019. The award was made on March 1, 2016 without a set-aside...
The Department of the Army Medical Command awarded Abbott Laboratories Inc., a health care company, a firm fixed price purchase order for $449,961.98 to provide clinical chemistry and immunoassay testing services, automated analyzers, reagents, test kits, and associated equipment and consumables. This award is not associated with a set-aside program. Abbott Laboratories Inc., through its Abbott Diagnostics Division, has provided a wide variety of goods and services to federal agencies including the Department of Veterans Affairs, the Defense Health Agency, and the Department of Justice's Bureau of Prisons. Abbott utilizes existing General Services Administration Federal Supply Schedule contracts and other indefinite delivery vehicles to streamline the procurement process and rapidly fulfill federal clinical laboratory requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Funding Only Action | ($154k) | 5/10/22 | |
| P00002 | Funding Only Action | ($600k) | 7/27/21 | |
| P00001 | Funding Only Action | ($450k) | 6/11/21 | |
| Not listed | Not listed | $1.7m | 3/26/21 |